This site uses technical cookies and profiling third party cookies to offer a better user experience; third party cookies require your consent. By continuing to browse the site, clicking or tapping the screen, scrolling the web page or closing this banner, you are agreeing to our use of cookies. For further information or opt out options.
IMA is loading
fabio 29
Array
(
    [post_type] => webinar
    [posts_per_page] => -1
    [fields] => ids
    [meta_query] => Array
        (
            [0] => Array
                (
                    [key] => minisite
                    [value] => 29
                )

        )

    [orderby] => date
    [order] => DESC
)

Can't stop the future • Live Streaming | September 26-27, 2019

Spotlight on Continuous Manufacturing for Oral Solid Dosage forms. The event was broadcasted in Live Streaming, english language. Every speech is now available on demand.

Full conference speeches now available on demand

Thank you everybody for taking part to “Can’t stop the future”, the conference organized
by IMA Active dedicated to the latest developments in the field of Continuous Manufacturing
with speakers representatives from FDA, MIT, ISPE, CONTINUUS Pharmaceuticals,
Patheon, Johnson & Johnson, Teva, Emerson, Colorcon
.

The event was broadcasted in Live Streaming on IMA TV
and starting from now every speech is available on demand.

List of interventions

Control strategies for continuous manufacturing

access_time
38 min
keyboard_voice
Alan Johnston

Alan Johnston is Senior Life Sciences Consultant at Emerson’s Global consultancy team. He has spent a majority of his career in the Life Sciences industry with a broad range of technical and business experience across production, automation and digitalization including Primary, Secondary and Vaccine manufacture. He has previously held senior technical roles at Siemens, Novartis Vaccines and GSK.

Go to Speech

How to implement and validate continuous manufacturing of direct compression tablets: challenges and opportunities

access_time
47 min
keyboard_voice
Frank Streil

Frank Streil is Director Technical and Scientific Aairs at Teva/RATIOPHARM. His main interests and experience are in the field of process development and validation as well as in new technologies, PAT and Continuous Manufacturing.

Go to Speech

Making the switch from batch to continuous manufacturing: an industrial perspective

access_time
45 min
keyboard_voice
Giustino Di Pretoro

Giustino Di Pretoro is Associate Director at Janssen Pharmaceutica, a Johnson & Johnson Company. He is a subject matter expert and drug product development lead for Continuous Manufacturing, and coordinator for a series of academic collaborations within the field of continuous.

Go to Speech

Dynamic process models for continuous encapsulation processes

event
September 27, 2019 - 09:00 am
access_time
35 min
keyboard_voice
Keirnan LaMarche

Keirnan LaMarche is Senior Principal Scientist at Patheon. He is an expert in solid dosage form design, continuous manufacturing, and he received his PhD in chemical Engineering from Rutgers University in 2008. He gained 10 years of experience in solid dosage form development at Bristol-Myers Squibb.

Go to Speech

Integrated continuous manufacturing with new technologies: pilot plant implementation

access_time
45 min
keyboard_voice
Salvatore Mascia

Salvatore Mascia is the Founder and CEO of CONTINUUS Pharmaceuticals. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end Continuous Manufacturing process for pharmaceuticals.

Go to Speech

IMA’s way from batch to continuous

access_time
54 min
keyboard_voice
Guia Bertuzzi

Guia Bertuzzi is Product Manager at IMA Active division since 2005. She has been working in mixing, granulation and powders handling systems for more than 20 years. She is expert in pharmaceutical engineering and process for Active Pharmaceutical Ingredients and Oral Solid Dosage forms.

Go to Speech

Global regulatory implementation on continuous manufacturing

access_time
60 min
keyboard_voice
Moheb M. Nasr

Moheb M. Nasr managed the CDER Pharmaceutical Analysis Program at the US FDA for four years and had the lead of the CDER/FDA CMC Regulatory Program for more than eight years. He also worked for GSK as VP Global CMC Strategy. In 2018 he started his own consultancy business.

Go to Speech

Continuous manufacturing: state of the art, challenges, and future prospects

access_time
45 min
keyboard_voice
Bernhardt L. Trout

Bernhardt L. Trout is Professor of Chemical Engineering at MIT and Director of Novartis-MIT Center for Continuous Manufacturing. His research focuses on the development of advanced manufacturing processes and rational tools for formulation and product design.

Go to Speech

Resources

attachment
Control strategies for continuous manufacturing - Alan Johnston
attachment
How to implement and validate continuous manufacturing of direct compression tablets: challenges and opportunities - Frank Streil
attachment
Making the switch from batch to Continuous Manufacturing an industrial perspective - Giustino Di Pretoro
attachment
Dynamic process models for continuous encapsulation processes - Keirnan LaMarche
attachment
Integrated Continuous Manufacturing with new technologies pilot plant implementation - Salvatore Mascia
attachment
IMA's way from batch to continuous - Guia Bertuzzi
attachment
Global regulatory implementation on Continuous Manufacturing - Moheb Nasr
attachment
Continuous Manufacturing state of the art, challenges and future prospects - Bernhardt L.Trout
attachment
True Modular Design for OSD Continuous Manufacturing Equipment - Laurence De Belder
attachment
CROMA Magazine
attachment
IMA Active brochure
list View full list